Renin-angiotensin system component gene polymorphisms in Japanese maintenance haemodialysis patients

Nephrology

Volumn 3, Issue 4, 1997, Pages 521-526

  Kawada, Noritaka ^a   Moriyama, Toshiki ^a,f   Yokoyama, Kenji ^a   Yamauchi, Atsushi ^a   Ando, Akio ^b   Mikami, Hiroshi ^c   Fujii, Masamitu ^d   Kajimoto, Yoshiteru ^e   Horio, Masaru ^a   Imai, Enyu ^a  

^a First Dept of Internal Medicine   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Higashi Kori Hospital   (Japan)

^d Osoka Kosei Nenkin Hospital   (Japan)

^e Kajimoto Clinic   (Japan)

^f OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

ACE I D; Agt T235 M235; AGT1R A1166 C1166; Haemodialysis; Polymorphism

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; RENIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 6844250990     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00236.x     Document Type: Article

References (33)

1. Hall J, Guyton A. Control of sodium excretion and arterial pressure by intrarenal mechanims and the renine-angiotensin system. In: Laragh JH, Brenner BM. (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press, New York NY. 1990; 1106-29.
2. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-coverting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
3. Ohishi M, Fujii K, Minamino T. A potent genetic risk factor for restenosis. Nature Genet. 1993; 5: 324-5.
4. Raynolds M, Taft C, Perryman B. Angiotensin-coverting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
5. Schunkert H, Hense H, Holmer S et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 1994; 330: 1634-8.
6. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 910-3.
7. Kamitani A, Rakugi H, Higaki J et al. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25: 950-3.
8. Oike Y, Hata A, Ogara Y, Numata Y, Shido K, Kondo K. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. J Clin. Invest. 1995; 96: 2975-9.
9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensinogen I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343-6.
10. Jeunemaitre X, Soubrier F, Kotelevstev Y et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169-80.
11. Caulfield M, Lavender P, Farrall M et al. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 1994; 330: 1629-33.
12. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63-9.
13. Yoshida H, Mitarai T, Kawamura T et al. Role of deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 1995; 96: 2162-9.
14. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin. Nephrol. 1995; 44: 80-5.
15. Harden P, Geddes, C, Rowe P et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-2.
16. Hunley T, Julian B, Phillips III J et al. Angiotensin converting enzyme gene polymorphism; potential silencer motief and impact on progression in IgA nephropathy. Kidney Int. 1996; 49: 571-7.
17. Marre B, Bernadet P, Gallois Y et al. Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 384-8.
18. van Essen G, Rensma P, de Zeeuw D et al. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347: 94-5.
19. Tarnow L, Cambien F, Rossing P et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy in IDDM patients. Diabetes 1995; 44: 489-94.
20. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 1995; 47: 1176-81.
21. Schmidt S, Stier E, Hartung R et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am. J. Kidney Dis. 1995; 26: 727-31.
22. Kawasaki E. Sample preparation from blood cells, and other fluids. In: Michael A, Gelfand DH, Sninsky JJ, White TJ (eds). PCR protocols. A Guide to Methods and Applications. Academic Press Limited, San Diego, 1990; 146-52.
23. Tiret L, Rigat B, Visvikise S. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 1992; 51: 197-205.
24. Shanmugam V, Sell K, Saha B. Mistyping ACE heterozygotes. PCR Meth. Appl. 1993; 3: 120-1.
25. Lindpaintner K, Pfeffer M, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 1995; 332: 706-11.
26. Ward K, Hata A, Jeunemaitre X et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet. 1993; 4: 59-61.
27. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25: 688-93.
28. Yamakawa K, Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 1995; 346: 515.
29. Fukushima T, Nomura S, Kawai S, Osawa G. ACE genotype and progression of IgA nephropathy. Lancet 1995; 346: 571.
30. Schmidt A, Kiener HP, Bamas U et al. Angiotensin-converting enzyme polymorphism in patients with terminal renal failure. J. Am. Soc. Nephrol. 1996; 7: 314-7.
31. Nomura H, Koni I, Michishita Y, Morise T, Takeda R. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 1994; 343: 482-3.
32. Yoshida H, Kuriyama S, Atsumi Y et al. Angiotensin I converting enzyme polymorphism in non-insulin dependent diabetic mellitus. Kidney Int. 1996; 50: 657-64.
33. Hata A, Namikawa C, Sasaki M. Angiotensinogen as a risk factor for essential hypertension in Japan. J. Clin. Invest. 1994; 93: 1285-7.